Scope Fluidics Spolka Akcyjna (FRA:S84) FCF Margin %: -73,133.33% (As of Mar. 2026)


FRA:S84 Scope Fluidics Spolka Akcyjna FRA:S84
44 GF Score
Price €23.70
GF Value €26.28
! 4 Warning Signs
View Full Analysis

What is Scope Fluidics Spolka Akcyjna FCF Margin %?

Scope Fluidics Spolka Akcyjna FRA:S84 +0.64% 44 FCF Margin % is -73,133.33% as of Mar. 2026. GuruFocus rates FRA:S84 with a GF Score™ of 44/100 and a GF Value™ of €26.28. The stock has 4 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Scope Fluidics Spolka Akcyjna ranks worse than 100% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Scope Fluidics Spolka Akcyjna's Free Cash Flow for the three months ended in Mar. 2026 was €-4.39 Mil. Scope Fluidics Spolka Akcyjna's Revenue for the three months ended in Mar. 2026 was €0.01 Mil. Therefore, Scope Fluidics Spolka Akcyjna's FCF Margin % for the quarter that ended in Mar. 2026 was -73,133.33%.

As of today, Scope Fluidics Spolka Akcyjna's current FCF Yield % is -17.60%.

The historical rank and industry rank for Scope Fluidics Spolka Akcyjna's FCF Margin % or its related term are showing as below:

FRA:S84' s FCF Margin % Range Over the Past 10 Years
Min: -256850   Med: -15731.04   Max: -2114.21
Current: -63654.17


During the past 10 years, the highest FCF Margin % of Scope Fluidics Spolka Akcyjna was -2114.21%. The lowest was -256850.00%. And the median was -15731.04%.

FRA:S84's FCF Margin % is ranked worse than
100% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: -1.845 vs FRA:S84: -63654.17


Scope Fluidics Spolka Akcyjna FCF Margin % Related Terms


Scope Fluidics Spolka Akcyjna FCF Margin % Historical Data

* Premium members only.

The historical data trend for Scope Fluidics Spolka Akcyjna's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scope Fluidics Spolka Akcyjna FCF Margin % Chart

Scope Fluidics Spolka Akcyjna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -7,298.94 -4,116.67 -23,793.55 -60,260.87

Scope Fluidics Spolka Akcyjna Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -59,400.00 -2,616.45 -60,800.00 2,785.61 -73,133.33

FRA:S84 vs TMO, DHR, IDXX: FCF Margin % Comparison

For the Diagnostics & Research subindustry, Scope Fluidics Spolka Akcyjna's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scope Fluidics Spolka Akcyjna FCF Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Scope Fluidics Spolka Akcyjna's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Scope Fluidics Spolka Akcyjna's FCF Margin % falls into.


FRA:S84
44GF Score
Scope Fluidics Spolka Akcyjna FRA:S84
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scope Fluidics Spolka Akcyjna FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Scope Fluidics Spolka Akcyjna's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-13.86/0.023
=-60,260.87 %

Scope Fluidics Spolka Akcyjna's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-4.388/0.006
=-73,133.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -73,133.33% mean?
Scope Fluidics Spolka Akcyjna (FRA:S84) has a FCF Margin % of -73,133.33% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. According to the industry distribution chart, Scope Fluidics Spolka Akcyjna ranks #204 out of 204 companies in the Medical Diagnostics & Research industry.
Is Scope Fluidics Spolka Akcyjna's FCF Margin % too high?
Scope Fluidics Spolka Akcyjna's current FCF Margin % is -73,133.33%. Based on the distribution chart, Scope Fluidics Spolka Akcyjna ranks #204 out of 204 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Scope Fluidics Spolka Akcyjna has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Scope Fluidics Spolka Akcyjna's FCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Scope Fluidics Spolka Akcyjna ranks #204 out of 204 companies for FCF Margin %. This places Scope Fluidics Spolka Akcyjna in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. Scope Fluidics Spolka Akcyjna's current FCF Margin % is -73,133.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scope Fluidics Spolka Akcyjna stock overvalued right now?
Scope Fluidics Spolka Akcyjna (FRA:S84) has a current FCF Margin % of -73,133.33%. The stock's GF Value™ is €26.28, compared to a current price of €23.70 — trading 9.8% below its estimated fair value. The current FCF Margin % is -73,133.33%. Scope Fluidics Spolka Akcyjna's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Scope Fluidics Spolka Akcyjna (FRA:S84), the current FCF Margin % is -73,133.33% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scope Fluidics Spolka Akcyjna (FRA:S84) Overvalued in 2026?

Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna stock appears to be undervalued. The current stock price of €23.70 is trading 9.8% below its estimated GF Value™ of €26.28.

Key valuation signals for FRA:S84:

  • FCF Margin %: -73,133.33%
  • GF Value™: €26.28 vs. price of €23.70 (9.8% below fair value)
  • GF Score™: 44/100 with 4 warning signs

No single metric tells the full story. See the FRA:S84 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Scope Fluidics Spolka Akcyjna Business Description

Other Exchanges SCP:Poland
Address Duchnicka 3, Build 16, Entrance A, Warsaw, POL, 01-796
Scope Fluidics Spolka Akcyjna focuses on global challenges in health to develop diagnostic and med tech solutions. The company combines the expertise in microfluidic technology with the awareness of the challenges in medical diagnostics. It provides prototyping support for diagnostic services.
44GF Score

Get the complete analysis for FRA:S84

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€23.70
Price
€26.28
GF Value